NAC

ARS Pharmaceuticals Submits Response to FDA Complete Response Letter for neffy® (Epinephrine Nasal Spray)

Retrieved on: 
Wednesday, April 3, 2024

In February 2024, ARS Pharma announced the successful completion of the repeat dosing study of neffy in seasonal allergic rhinitis under NAC conditions.

Key Points: 
  • In February 2024, ARS Pharma announced the successful completion of the repeat dosing study of neffy in seasonal allergic rhinitis under NAC conditions.
  • ARS Pharma also completed the nitrosamine testing requested with no measurable levels of nitrosamines detected.
  • In May 2023, the FDA Advisory Committee (PADAC) determined a favorable benefit-risk profile for neffy (16:6 for adults and 17:5 for children).
  • ARS Pharma anticipates an FDA review period of up to six months, and the PDUFA date is anticipated to be October 2, 2024, based on the submission receipt date of April 2, 2024.

Fortinet Introduces Expansive Upgrades to its Real-Time Network Security Operating System to Empower Enterprises to Fortify Their Networks

Retrieved on: 
Tuesday, April 2, 2024

These integrations improve threat analysis and response and streamline network and security operations, respectively.

Key Points: 
  • These integrations improve threat analysis and response and streamline network and security operations, respectively.
  • Expanding FortiAI across the Fortinet Security Fabric facilitates faster decision-making, helps detect and remediate incidents quickly, and ensures organizations can easily adopt the technologies they require.
  • These FortiOS 7.6 enhanced features ensure sensitive information remains secure no matter where it resides within the hybrid network.
  • As part of the Fortinet Training Advancement Agenda (TAA), the Fortinet Training Institute also provides training and certification through the Network Security Expert (NSE) Certification , Academic Partner , and Education Outreach programs.

Kumar Kathinokkula Joins APCO Holdings, LLC as Chief Technology Officer

Retrieved on: 
Thursday, March 28, 2024

Norcross, GA, March 28, 2024 (GLOBE NEWSWIRE) -- APCO Holdings, LLC, a leading provider and administrator of automotive and RV F&I products and home to EasyCare, National Auto Care (NAC), GWC Warranty, and MemberCare brands, has announced that Kumar Kathinokkula has joined the company as Chief Technology Officer.

Key Points: 
  • Norcross, GA, March 28, 2024 (GLOBE NEWSWIRE) -- APCO Holdings, LLC, a leading provider and administrator of automotive and RV F&I products and home to EasyCare, National Auto Care (NAC), GWC Warranty, and MemberCare brands, has announced that Kumar Kathinokkula has joined the company as Chief Technology Officer.
  • Kumar brings over 30 years of experience in IT and product management with deep expertise in the F&I industry.
  • Kumar cofounded F&I Administration Solutions, the market leading company that pioneered the first SaaS F&I product administration platform for all F&I products.
  • After several years of rapid growth and a merger with another leading F&I solutions provider, Kathinokkula served as Chief Operations Officer and Board Member for the combined entity.

Revive Therapeutics Provides Corporate Update

Retrieved on: 
Tuesday, March 12, 2024

TORONTO, March 12, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced today a corporate update on the research, clinical and regulatory initiatives with Bucillamine and its long COVID diagnostic product.

Key Points: 
  • TORONTO, March 12, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced today a corporate update on the research, clinical and regulatory initiatives with Bucillamine and its long COVID diagnostic product.
  • Exposure to nerve agents can cause tightness of the chest, excessive salivation, abdominal cramps, diarrhea, blurred vision, tremors, and death.
  • In addition, Revive may evaluate the potential of its proposed long COVID diagnostic product as a companion to Bucillamine.
  • The Company, under its wholly-owned subsidiary Revive Diagnostics Inc., is advancing the product development of a potential blood biomarker diagnostic that characterizes long COVID.

CFP Board Imposes Public Sanctions on Nine Additional Individuals

Retrieved on: 
Friday, April 5, 2024

Robert P. Baffa Jr., CFP® (Las Vegas, Nevada): In January 2024, the Disciplinary and Ethics Commission (Commission) issued an order in which Mr. Baffa received a Public Censure.

Key Points: 
  • Robert P. Baffa Jr., CFP® (Las Vegas, Nevada): In January 2024, the Disciplinary and Ethics Commission (Commission) issued an order in which Mr. Baffa received a Public Censure.
  • Pursuant to his Consent Order with CFP Board, the Commission issued Mr. Ercole an Order of Public Censure.
  • Pursuant to this Consent Order with CFP Board, the Commission issued Ms. Hayut a Suspension of One Year and One Day.
  • This sanction followed the expiration of Mr. Kirkpatrick’s CFP® certification and his failure to file an Answer to CFP Board Enforcement Counsel’s Complaint within the required time frame.

QT Imaging’s Breast Acoustic CT™ Scanner Used in Study for Early Identification of Response of Breast Cancer Patients to Neoadjuvant Chemotherapy

Retrieved on: 
Thursday, March 14, 2024

This collaboration is part of a five-year research grant from National Institutes of Health/National Cancer Institute to develop an inexpensive, portable, safe, and repeatable imaging approach capable of accurate and early identification of response of breast cancer patients to neoadjuvant chemotherapy (NAC).

Key Points: 
  • This collaboration is part of a five-year research grant from National Institutes of Health/National Cancer Institute to develop an inexpensive, portable, safe, and repeatable imaging approach capable of accurate and early identification of response of breast cancer patients to neoadjuvant chemotherapy (NAC).
  • As part of this grant, Breast Acoustic CT™ (ACT) quantitative images with independent biomarkers known to be sensitive to cancer will be collected, and the response of cancer to therapy, will be derived from quantitative ultrasound based on backscatter analysis.
  • This collaboration also addresses the ongoing clinical need in breast cancer therapy for the development of an inexpensive, robust, and accurate technique to identify the response, within weeks, of breast cancer to neoadjuvant chemotherapy.
  • The early identification of non-responders to NAC or any cancer treatment remains a highly significant medical problem and necessary for adaptive precision medicine.

L&T Technology Services (LTTS) Secures Landmark ∼$100 Million Program in Cybersecurity

Retrieved on: 
Friday, March 15, 2024

L&T Technology Services Limited (LTTS) (BSE: 540115, NSE: LTTS), a leading global pure-play engineering and technology services company, announced today that it has won a first-of-its-kind program in India worth around $100 million from Maharashtra State Cyber Department, under the Government of Maharashtra.

Key Points: 
  • L&T Technology Services Limited (LTTS) (BSE: 540115, NSE: LTTS), a leading global pure-play engineering and technology services company, announced today that it has won a first-of-its-kind program in India worth around $100 million from Maharashtra State Cyber Department, under the Government of Maharashtra.
  • This initiative extends LTTS’ commitment to developing secure, digitally interconnected smart and safe cities through premier Cyber Security and Digital Forensic solutions consolidated under one umbrella.
  • View the full release here: https://www.businesswire.com/news/home/20240314467779/en/
    First-of-its-kind program in India entails designing a sophisticated cybersecurity system using AI & Digital Forensic tools.
  • Commenting on the milestone win, Amit Chadha, CEO and Managing Director of L&T Technology Services, said, "This first-of-its-kind deal is more than just a business achievement for us.

Nintex Introduces AI-Powered Automation Capabilities to Improve Organizational Efficiency

Retrieved on: 
Wednesday, March 27, 2024

Nintex has pioneered the use of AI within its automation platform for years, embedding advanced technologies such as computer vision, RPA, natural language processing, and more to speed up core business process automation.

Key Points: 
  • Nintex has pioneered the use of AI within its automation platform for years, embedding advanced technologies such as computer vision, RPA, natural language processing, and more to speed up core business process automation.
  • The latest features showcase the role of generative AI in powering process automation and making it much easier for customers to design on Nintex Process Platform.
  • Available today within DocGen® for Salesforce, Nintex Assistant will soon be available across the Nintex Process Platform.
  • To learn more about the new AI capabilities of the Nintex Process Platform, visit: https://www.nintex.com/process-intelligence/artificial-intelligence/ .

Nintex Introduces AI-Powered Automation Capabilities to Improve Organizational Efficiency

Retrieved on: 
Wednesday, March 27, 2024

Nintex has pioneered the use of AI within its automation platform for years, embedding advanced technologies such as computer vision, RPA, natural language processing, and more to speed up core business process automation.

Key Points: 
  • Nintex has pioneered the use of AI within its automation platform for years, embedding advanced technologies such as computer vision, RPA, natural language processing, and more to speed up core business process automation.
  • The latest features showcase the role of generative AI in powering process automation and making it much easier for customers to design on Nintex Process Platform.
  • Available today within DocGen® for Salesforce, Nintex Assistant will soon be available across the Nintex Process Platform.
  • To learn more about the new AI capabilities of the Nintex Process Platform, visit: https://www.nintex.com/process-intelligence/artificial-intelligence/ .

Dymium Emerges Out of Stealth with $7M in Funding Led by Two Bear Capital to Launch Zero Trust Data Security Platform with Secure AI Chat

Retrieved on: 
Wednesday, March 20, 2024

Dymium's unique data platform provides secure access to data "where it lives," eliminating the complexity, availability, and timeliness challenges of duplicating data into data warehouses or data lakes and making it far more secure from hackers and thieves.

Key Points: 
  • Dymium's unique data platform provides secure access to data "where it lives," eliminating the complexity, availability, and timeliness challenges of duplicating data into data warehouses or data lakes and making it far more secure from hackers and thieves.
  • Dymium CEO, Denzil Wessels, has focused his entire career on zero trust technology (he created Zscaler's zero trust solution).
  • The Dymium Platform is a session-aware data security platform that can get any user or application the data in real-time in the format desired.
  • With real-time data privacy controls and data transformation services across heterogeneous data sources, Dymium enables companies to transform data management without transforming their data.